Elefante Mark B - Q1 2016 holdings

$6.27 Million is the total value of Elefante Mark B's 77 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 42.9% .

 Value Shares↓ Weighting
CVS BuyCVS HEALTH$572,000
+65.3%
5,510
+55.6%
9.13%
-1.8%
FISV BuyFISERV$529,000
+61.8%
5,160
+44.1%
8.44%
-3.9%
JNJ BuyJOHNSON & JOHNSON$383,000
+57.6%
3,535
+49.5%
6.11%
-6.4%
MA BuyMASTERCARD$375,000
+19.8%
3,970
+23.3%
5.99%
-28.8%
AAPL BuyAPPLE INC$373,000
+25.2%
3,422
+20.6%
5.96%
-25.6%
PG BuyPROCTER & GAMBLE$353,000
+34.2%
4,295
+30.2%
5.64%
-20.3%
ADP BuyAUTOMATIC DATA PROCESSING$339,000
+39.5%
3,780
+31.2%
5.41%
-17.1%
MMM New3M$329,0001,975
+100.0%
5.25%
ATR BuyAPTARGROUP$324,000
+44.0%
4,135
+33.4%
5.17%
-14.5%
NSRGY BuyNESTLE SA ADR$315,000
+6.4%
4,230
+6.3%
5.03%
-36.8%
UTX BuyUNITED TECHNOLOGIES$286,000
+23.3%
2,850
+18.3%
4.57%
-26.8%
GOOGL BuyALPHABET INC CL A$270,0000.0%355
+2.3%
4.31%
-40.6%
NVS BuyNOVARTIS AG ADR$259,000
+6.6%
3,590
+27.5%
4.14%
-36.7%
ROK SellROCKWELL AUTOMATION$235,000
+10.8%
2,065
-0.5%
3.75%
-34.1%
CB NewCHUBB LIMITED$229,0001,923
+100.0%
3.66%
PEP NewPEPSICO$229,0002,232
+100.0%
3.66%
XOM NewEXXON MOBIL$227,0002,712
+100.0%
3.62%
SLB NewSCHLUMBERGER$226,0003,070
+100.0%
3.61%
ABT BuyABBOTT LABS$208,000
-1.0%
4,965
+5.9%
3.32%
-41.2%
ORCL NewORACLE$203,0004,955
+100.0%
3.24%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FISERV19Q2 20208.8%
MASTERCARD19Q2 20208.4%
APPLE INC19Q2 20208.0%
ALPHABET INC CL A19Q2 20207.3%
JOHNSON & JOHNSON19Q2 20206.5%
PROCTER & GAMBLE19Q2 20207.1%
AUTOMATIC DATA PROCESSING19Q2 20206.5%
ABBOTT LABS19Q2 20205.6%
NESTLE SA ADR19Q2 20208.0%
NOVARTIS AG ADR19Q2 20206.5%

View Elefante Mark B's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-07-28
13F-HR2020-05-07
13F-HR2020-01-15
13F-HR2019-11-06
13F-HR2019-07-24
13F-HR2019-05-02
13F-HR2019-01-24
13F-HR2018-10-15
13F-HR2018-07-30
13F-HR2018-04-24

View Elefante Mark B's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (6265000.0 != 6264000.0)

Export Elefante Mark B's holdings